Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,800 shares, a drop of 98.7% from the February 29th total of 141,600 shares. Based on an average trading volume of 3,144,000 shares, the short-interest ratio is presently 0.0 days.
Analyst Upgrades and Downgrades
RBGLY has been the subject of a number of research analyst reports. BNP Paribas upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Tuesday, January 9th. Jefferies Financial Group lowered shares of Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a report on Monday, December 11th. Finally, Sanford C. Bernstein raised Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a research note on Monday, December 11th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $6,978.00.
Read Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Increases Dividend
The firm also recently declared a dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, April 12th will be given a dividend of $0.2701 per share. The ex-dividend date is Thursday, April 11th. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- The Significance of Brokerage Rankings in Stock Selection
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Are Penny Stocks a Good Fit for Your Portfolio?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is a SEC Filing?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.